Showing 1 - 10 of 325
Persistent link: https://www.econbiz.de/10011798206
Persistent link: https://www.econbiz.de/10014286996
Persistent link: https://www.econbiz.de/10003687901
Persistent link: https://www.econbiz.de/10012921996
English Abstract: Compliance programs are an invaluable tool in preventing antitrust violations. Some argue that the increased risk of cartel discovery stemming from the implementation of leniency programs, which help competition authorities uncover cartels, already provides sufficient incentive...
Persistent link: https://www.econbiz.de/10012923550
This paper discusses the possible significance of the recent Empagran decision of the US Supreme court for the extraterritorial enforcement of competition law. In this decision the US Supreme rejected the claim of foreign plaintiff suing in the US another foreign firm which had participated in...
Persistent link: https://www.econbiz.de/10005021691
Si la Suisse a depuis deux ans un droit de la concurrence largement modernisé et compatible avec celui d'autres juridictions telles que la Communauté, la mise en oeuvre de cette nouvelle politique doit être encore améliorée. En effet, la qualité des décisions laisse sérieusement à...
Persistent link: https://www.econbiz.de/10005518857
La croissance économique française sur la dernière décade s'est avérée insuffisante pour résorber un taux de chômage élevé et persistant. Les études et comparaisons internationales disponibles suggèrent qu'un renforcement du degré de concurrence permettrait d'améliorer...
Persistent link: https://www.econbiz.de/10012441999
This article analyses the interaction between competition, productive models and financialisation of the main pharmaceutical companies. After having studied the institutional specificities and the constraints that shape productive models, we analyze how transformations of ownership structures...
Persistent link: https://www.econbiz.de/10005697626
This article analyses the interaction between competition, productive models and financialisation of the main pharmaceutical companies. After having studied the institutional specificities and the constraints that shape productive models, we analyze how transformations of ownership structures...
Persistent link: https://www.econbiz.de/10005395050